"Find the full range of health and wellness care from Fisher-Titus Medical Center in Norwalk, Ohio. Our mission is to provide safe, quality health care in a cost effective manner while respecting the dignity and uniqueness of each individual we serve."

During the past decade, Fisher-Titus Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 47 clinical trials were completed, i.e. on average, 4700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fisher-Titus Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fisher-Titus Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Fisher-Titus Medical Center" are "Breast Cancer" (6 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (4 trials), "Clear Cell Renal Cell Carcinoma" (3 trials), "Metastatic Cancer" (3 trials) and "Pain" (3 trials). Many other conditions were trialed in "Fisher-Titus Medical Center" in a lesser frequency.

Most popular intervention types in "Fisher-Titus Medical Center" are "Drug" (48 trials), "Other" (33 trials), "Biological" (27 trials), "Procedure" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Bevacizumab" (10 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials) and "placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Fisher-Titus Medical Center" are 44 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Fisher-Titus Medical Center". undefined are not yet recruiting, 1 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Fisher-Titus Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Fisher-Titus Medical Center, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".